koselugo
astrazeneca ab - selumetinib sulfate - neurofibromatosis 1 - agenti antineoplastici - koselugo as monotherapy is indicated for the treatment of symptomatic, inoperable plexiform neurofibromas (pn) in paediatric patients with neurofibromatosis type 1 (nf1) aged 3 years and above.
kos rodiola sinergico gocce integratore alimentare 100ml
kos srl -
kos partenio estratto secco integratore alimentare 60 compresse
kos srl -